Erik Larsson

60.8k citations

208 papers · 34.1k indexed · 5 hit papers · h-index 56

Impact in

Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Molecular Biology top 0.05%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing

Papers in

Transplantation 14
- Renal Transplantation Outcomes and Treatments 14
Cancer Research 43
- Cancer Genomics and Diagnostics 17
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 11

Co-authors: Chris Sander Nikolaus Schultz Anders J. Skanderup Bülent Arman Aksoy Uğur Doğrusöz Jianjiong Gao Benjamin Groß S. Onur Sumer
Journals: Transplant International (9 papers)PLoS ONE (8 papers)Nature Communications (8 papers)Transplantation (8 papers)International Journal of Cancer (7 papers)
Partner nations: Sweden United States Germany

In The Last Decade

Erik Larsson

207 papers receiving 33.7k citations

Hit Papers

5 papers align trajectories log scale

Antioxidants Accelerate Lung Cancer Progression in Mice 2014 · 656 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Science Translational Medicine
2013 Science Signaling
2012 Cancer Discovery
2012 Bioinformatics
1994 Genes & Development

Peers

Countries citing papers authored by Erik Larsson

Since Specialization

Citations

This map shows the geographic impact of Erik Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Larsson more than expected).

Fields of papers citing papers by Erik Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Larsson. The network helps show where Erik Larsson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erik Larsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Larsson Line = papers co-authored together Erik Larsson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors Redox Biology ·Anouck Bahnerth, I Carlo Di, David Walker, Maureen Higgins, Vitor Soares Ribeiro, Donna K. Lyon, 正春永嶋, Hui Hui Fu, Richard M. Karpt, Tomasz Wenta, Erik Larsson, Clotilde Wiel, Volkan I. Sayin, Laureano de la Vega	2025	1
2	Reclassification of eleven corticioid basidiomycetes with nine typifications PubMed ·Karl Henrik Larsson, Viacheslav Spirin, Leif Ryvarden, Erik Larsson	2025	1
3	Mechanistic basis of atypical TERT promoter mutations Nature Communications ·Kerryn Elliott, Vinod Kumar Singh, Shuofei Zhang, Zoulikha Ouchenane, İsa Aydın, Katarzyna M. Soczek, Emily Hoberg, James W. Sch Christopher J. Schenk, Jimmy Van den Eynden, Maria Falkenberg, Jennifer A. Doudna, Anders Ståhlberg, Erik Larsson	2024	5
4	High mitochondrial DNA levels accelerate lung adenocarcinoma progression Science Advances ·Mara Mennuni, NM Howes, Said Benjamin Bonakdar, David Alsina, Roberta Filograna, İsa Aydın, David E. Sanin, Florian A. Rosenberger, N Pisanu, Erik Larsson, Erika L. Pearce, Nils‐Göran Larsson	2024	7
5	DamID transcriptional profiling identifies the Snail/Scratch transcription factor Kahuli as an Alk target in the Drosophila visceral mesoderm Development ·Patricia Mendoza-García, Swaraj Basu, R. Jedliński, Badrul Arefin, Georg Wolfstetter, Beatriz de Castro Carvalho Coelho, E. B. Murav’eva, M. Ram�n-Medrano, Sofi Fuad Habybi, Cristina Lebrero‐Fernández, Jan Larsson, Erik Larsson, Mats Bemark, Ruth H. Palmer	2021	6
6	Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing Brain Pathology ·Carola Hedberg‐Oldfors, Menyu Guo, Swaraj Basu, Kanan Tooru, Christopher Lindberg, Maria Falkenberg, Erik Larsson, Володимир Ференс	2020	20
7	Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing PLoS Genetics ·Swaraj Basu, Xie Xie, Jay P. Uhler, Carola Hedberg‐Oldfors, Dusanka Milenkovic, Olivier R. Baris, F.a. Hayek, Stanka Matic, James B. Stewart, Nils‐Göran Larsson, Rudolf J. Wiesner, Anders Oldfors, Claes M. Gustafsson, Maria Falkenberg, Erik Larsson	2020	43
8	Intragenomic variability and extended sequence patterns in the mutational signature of ultraviolet light Proceedings of the National Academy of Sciences ·İsa Aydın, Thyssia Rodrigues Figueiredo Collins, Kerryn Elliott, Erik Larsson	2019	18
9	DNA polymerase η contributes to genome-wide lagging strand synthesis Nucleic Acids Research ·LI HuaIin, Martin K. M. Engqvist, Lianzhong Ai, Geyu Dong, Thyssia Rodrigues Figueiredo Collins, Clara Navarrete, John P. McDonald, Erik Larsson, Roger Woodgate, Anders R. Clausen	2018	16
10	Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma PLoS ONE ·Ananya Roy, Julia Femel, Elisabeth J. M. Huijbers, Dorothe Spillmann, Erik Larsson, Maria Ringvall, Anna‐Karin Olsson, Magnus Åbrink	2016	21
11	Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets RNA ·Thalia A. Farazi, Carl-Stephan Leonhardt, Neelanjan Mukherjee, Aleksandra Mihailović, Song Li, Klaas E.A. Max, Cindy Meyer, Masashi Yamaji, Pavol Čekan, Panigrahy Saroj Kumar, Stefanie Gerstberger, José Godoy Bezerra de Souza, Erik Larsson, Uwe Ohler, Thomas Tuschl	2014	43
12	Zinc Finger Protein 148 Is Dispensable for Primitive and Definitive Hematopoiesis in Mice PLoS ONE ·Sara Oduber Martorell, Volkan I. Sayin, Anna Staffas, Erik Larsson, Julia Rolf, Marleen M.R. Petit, Lars Palmqvist, Birgitta Swolin, Susanna Cardell, Per Lindahl	2013	5
13	The Uppsala Experience of Switching from Cni:s to Belatacept after Kidney Transplantation Transplant International ·Dávila Soto, Lars Bäckman, Ali‐Reza Biglarnia, 钢添朱, Erik Larsson, Tomas Lorant, Roberto Solís-Hérnández, Thomas Nilsson, Amir Sedigh, Gunnar Tufveson	2013	1
14	LC–MS/MS characterization of combined glycogenin-1 and glycogenin-2 enzymatic activities reveals their self-glucosylation preferences Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Johanna Nilsson, (unknown), Adnan Halim, Erik Larsson, Ali‐Reza Moslemi, Anders Oldfors, Göran Larson, Jonas Nilsson	2013	13
15	Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma PLoS ONE ·Chad J. Creighton, John Rothfork, Anders J. Skanderup, Douglas A. Levine, Parminder K. Mankoo, Nikolaus Schultz, Ying Du, Yiqun Zhang, Erik Larsson, Robert P. Sheridan, Weimin Xiao, Paul T. Spellman, Gad Getz, David A. Wheeler, Charles M. Perou, Richard A. Gibbs, Chris Sander, D. Neil Hayes, Preethi H. Gunaratne	2012	98
16	RNA targets of wild-type and mutant FET family proteins Nature Structural & Molecular Biology ·Jessica I. Hoell, Erik Larsson, P.U. Lima, Jeffrey D. Nusbaum, Sujitha Duggimpudi, Thalia A. Farazi, Markus Hafner, Arndt Borkhardt, Chris Sander, Thomas Tuschl	2011	282
17	Hypoxic regulation of secreted proteoglycans in macrophages Glycobiology ·Annika Asplund, Pia Stillemark-Billton, Erik Larsson, Ellen Knutsen Rydberg, Jonatan Moses, Lillemor Mattsson Hultén, Björn Fagerberg, Germán Camejo, Göran Bondjers	2009	44
18	Developmental Expression of HERV-R (ERV3) and HERV-K in Human Tissue Virology ·Ann‐Catrin Andersson, Patrick J Venables, Ralf R. Tönjes, Jürgen Scherer, Lars Eriksson, Erik Larsson	2002	64
19	Age-dependent Modulation of Heparan Sulfate Structure and Function Journal of Biological Chemistry ·Emadoldin Feyzi, Tom Saldeen, Erik Larsson, Ulf Lindahl, Markku Salmivirta	1998	130
20	Immunohistochemical Detection of the Melanocortin 1 Receptor in Human Testis, Ovary and Placenta using Specific Monoclonal Antibody Hormone Research ·Marie Gauthier, G Kokilam, Valerio Saliani, Erik Larsson, Vijay Chhajlani	1997	23

About Erik Larsson

Erik Larsson is a scholar working on Transplantation, Cancer Research, Nephrology, Molecular Biology and Immunology and Allergy, having authored 208 papers that have together received 34.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), RNA Research and Splicing (18 papers), Cancer Genomics and Diagnostics (17 papers), Organ Transplantation Techniques and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (14 papers), Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and Proteoglycans and glycosaminoglycans research (11 papers). The work is most often cited by research in Cancer Research (9.7k citations), Molecular Biology (21.9k citations), Oncology (8.3k citations), Pulmonary and Respiratory Medicine (6.9k citations) and Immunology (3.7k citations). Erik Larsson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Chris Sander, Nikolaus Schultz, Anders J. Skanderup, Bülent Arman Aksoy, Uğur Doğrusöz, Jianjiong Gao, Benjamin Groß, S. Onur Sumer, Ethan Cerami and Gideon Dresdner. Their work appears in journals such as Transplant International, PLoS ONE, Nature Communications, Transplantation and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact